Familial hypercholesterolaemia
KEYWORDS: people, diagnosis, quality, statement, data, treatment, testing, clinical, children, specialist, hypercholesterolaemia, familial hypercholesterolaemia, clinical diagnosis, familial, source

baseline total cholesterol above 7.5 mmol/l who are assessed for a clinical diagnosis of FH. Numerator – The number of people in the denominator assessed for a clinical diagnosis of FH. Denominator – The number of adults with a baseline total cholesterol above 7.5 mmol/l. Data source: Local data collection. What the quality statement means for different audiences Service providers ensure that systems are in place for adults with a baseline total cholesterol above 7.5 mmol/l to be assessed for a clinical diagnosis of FH. General practitioners assess adults with a baseline total cholesterol above 7.5 mmol/l for a clinical diagnosis of FH. Commissioners ensure that they commission services that identify and assess adults with a baseline total cholesterol above 7.5 mmol/l for a clinical diagnosis of FH. Adults with a total cholesterol above 7.5 mmol/l before treatment have an assessment for FH. Source guidance Familial hypercholesterolaemia: identification and management. NICE guideline CG71 (2008, updated 2019), recommendations 1.1.1, 1.1.2, 1.1.4, 1.1.5 and 1.1.9 Definitions of terms used in this quality statement Adults People aged 16 and older. Baseline total cholesterol The total cholesterol concentration before treatment. Familial hypercholesterolaemia (FH) FH relates to heterozygous FH only. Clinical diagnosis of FH Assessment
